FINANCIAL NEWS

ASX Winners And Losers Of Today – 10-08-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Aug 10 2026


Weak Market, But James Hardie Is Confident

Amidst a difficult US housing market backdrop, James Hardie is concentrating on further organic growth following a strong first quarter

Aug 10 2026


FNArena Corporate Results Monitor – 10-08-2026

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Aug 10 2026


Australian Broker Call *Extra* Edition – Aug 10, 2026

Extra Edition of the Broker Call Report

Aug 10 2026


Australian Listed Real Estate Tables – 10-08-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

Aug 10 2026


Morgans rates COF as Trim

Centuria Office REIT posted a FY26 result that was largely in line with expectations and guidance. FY27 guidance comprises FFO of 11.3 cents and a distribution of nine cents, equating to a distribution yield of 10.1% and 79.6% payout ratio.

Morgans observes the balance sheet remains a constraint, with gearing at 43.7%. Leasing volumes were encouraging amongst the strongest in the REIT's history, although this is yet to translate into occupancy.

The prospect of higher interest rates compounds headwinds for a leveraged portfolio with limited near-term earnings growth and Morgans retains a Trim rating with the target rising to $0.88 from $0.80.

UBS rates FPH as Neutral

Ahead of Fisher & Paykel Healthcare's result, UBS' analysis points to strong growth in devices (25%) and consumables (17%). Devices sales look to be supported by MR950 and Airvo3 rollout.

UBS expects first half profit up 27% on NZ$ revenue growth of 21% and modest margin expansion. The broker also lifts forecast EPS by 3% due to faster anaesthesia adoption, higher hospital device sales and stronger NZ$/hedging gains.

Target rises to NZ$42.00 from NZ$37.50, Neutral retained.

Citi rates NCK as Neutral

Post the initial take below, Citi views the FY26 result as showing strong execution on gross margins and operating expenses.

Better margins offset the sales shortfall, while the 39cps final dividend was well ahead of 31.8cps consensus.

The analyst emerged from the conference call more positive but remains cautious on the A&NZ housing cycle, seeing downside risk to earnings over 1H27 and potentially beyond as comparables become more difficult.

Citi economics forecasts one more RBA rate hike in November and questions whether one or two subsequent rate cuts would improve the housing cycle given housing policy changes announced in the May Federal Budget.

Target $17.25, Neutral rated.

***

On first take, Citi notes Nick Scali's FY26 net profit after tax of $75.7m was in line with consensus.

Sales missed consensus by -3% but more robust margins were an offsetting factor.

The UK operated at breakeven, which is viewed positively. Cost of doing business was flat. The UK gross margin moved up to 61.2% in 2H from 59.2% in 1H.

On the not so positive side, UK like-for-like sales fell -19% and for FY26 missed consensus expectations by -13%.

A&NZ like-for-like sales missed consensus by -4% in terms of a flat outlook and trading update for FY27, but the metric is muddied by new store growth over 5% in the same period, the broker highlights.

Citi believes the result will be positively received due to the short interest and the low investor ownership.

The results and trading update reflect, in the analysts' view, the more upbeat outlook prior to the May budget, given furniture sales lag property contracts by 3-6 months.

Neutral. Target $14.50.

Click here to see full report market arrow icon

ANALYSIS & DATA

FNARENA'S MARKET CONSENSUS FORECASTS

To display the stock analysis for a company please enter the company code:

ANZ | ANZ GROUP HOLDINGS LIMITED

Abbreviated format - see the full version here


LAST PRICECHANGE +/-CHANGE %VOLUME

$37.73

07 Aug
2026

market red arrow -0.380

OPEN

$37.95

market red arrow -1.00%

HIGH

$38.00

3,154,703

LOW

$37.56

TARGET
$35.017-7.2% downside
Franking for last dividend paid out: 75%
FNARENA'S MARKET CONSENSUS FORECASTS
ANZ: 1
TitleFY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps)xxx 198.2 245.1xxx
DPS (cps)xxx 166.0 166.8xxx
EPS Growthxxx- 9.1% 23.7%xxx
DPS Growthxxx 0.0% 0.5%xxx
PE RatioxxxN/A 15.1xxx
Dividend YieldxxxN/A 4.5%xxx
Div Pay Ratio(%)xxx 83.8% 68.1%xxx

FOLLOW US ON SOCIAL MEDIA

9.1K Followers
26.7K Posts
@Filapek
Rudi Filapek-Vandyck@Filapek
3h
Citi on $Car Group: "We are a bit surprised with the quantum of the share price reaction and while a weaker macro could result in revenue growth coming in towards bottom-end of range, we do see the ongoing product development as positive and should underpin double-digit growth
@Filapek
Rudi Filapek-Vandyck@Filapek
7h
RBC Capital on Megaport $MP1: "Recent CEO meetings we hosted with US investors highlighted: "1) Megaport has transformed from a cloud-connectivity company into a three-pillar platform (network, compute, storage) post its Latitude acquisition, aimed at meeting on-demand
@Filapek
Rudi Filapek-Vandyck@Filapek
7h
RBC Capital on Integral Diagnostics $IDX: "The company has provided preliminary results for FY26, which came in below consensus expectations. "While we had flagged downside risks to consensus numbers in our preview note, we expect the operating miss to be taken negatively by
@Filapek
Rudi Filapek-Vandyck@Filapek
8h
RBC Capital on $CAR Group: "A largely in-line result from CAR with good guidance relative to present FY27 consensus expectations. "Not a lot of surprises even divisionally (ex. Investments) with segment beats and misses for both revenue and EBITDA not exceeding 3%. "With
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
Citi on ResMed $RMD: "Following in-line sales for 4Q26 we have revised our FY27E revenue to include lower impact from the Astral recall than we previously assumed (USD75m vs USD200m) but tempered our gross margin expansion expectations. "A USD1.5b buyback (USD500m more than
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
That sound you are hearing in the background is from me having a good ole belly laugh 😉 - Spicing up the FriJay! https://t.co/bafCGlhA00
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
Citi on James Hardie $JHX: "1Q27 EBITDA $422M, oddly ~4% over the top end of pre-reported range ($399-407M). "With S&T and DR&A within previous ranges, and guidance provided post quarter end, it appears the driver was share-based comp put below the line that provided a ~$15M
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
RBC Capital on James Hardie $JHX: "We expect a positive reaction in James Hardie's shares in trading today after the release of FQ127 results, which follows the company's preliminary results release from July 22. "We expect a positive reaction to the strong quarter and raised
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
Citi on ResMed $RMD: "RMD's 4Q sales were in line with VA consensus with devices and masks both in line, but a stronger performance ex-Americas than in the Americas. "Gross margin was 46bps below consensus, although slightly ahead of our estimate. EPS was 2% ahead, but R&D
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
RBC Capital on ResMed $RMD: "Revenue was in line with consensus expectations, with a slight miss in Americas and SaaS being offset by a beat in RoW. "Gross margin was a miss to RBCe and Consensus and non-GAAP income from operations was a miss due to the lower gross margin and
FIND FNARENA ON

DAILY FINANCIAL NEWS

Weak Market, But James Hardie Is Confident

Amidst a difficult US housing market backdrop, James Hardie is concentrating on further organic growth following a strong first quarter

Aug 10 2026 - Australia


FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Aug 10 2026 - Australia


Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Aug 08 2026 - Australia


FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Aug 07 2026 - Australia


Multi-affiliate asset manager Pinnacle Investment Management beat consensus on funds under management but fell well short on profit

Aug 07 2026 - Australia


FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Aug 06 2026 - Australia


rudi fnarena picture

RUDI'S VIEWS

Rudi’s View: That’s The Way Markets Crumble

JPMorgan remains bullish on AI and US equities. Plus a line-up of the latest Best Buy nominations and Conviction Calls ahead of August results

Aug 06 2026

DAILY MARKET REPORTS

ASX Winners And Losers Of Today – 10-08-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Aug 10 2026


Australian Broker Call *Extra* Edition – Aug 10, 2026

Extra Edition of the Broker Call Report

Aug 10 2026


The Monday Report – 10 August 2026

Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

Aug 10 2026


Today’s Financial Calendar – 10-08-2026

Significant Scheduled Events For 10 August, 2026

Aug 10 2026


ASX Winners And Losers Of Today – 07-08-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Aug 07 2026


The Overnight Report: Oil Up, Software Down

A global perspective on what happened overnight

Aug 07 2026


Today’s Financial Calendar – 07-08-2026

Significant Scheduled Events For 07 August, 2026

Aug 07 2026


WEEKLY REPORTS

Australian Listed Real Estate Tables – 10-08-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

Aug 10 2026

Weekly Ratings, Targets, Forecast Changes – 07-08-26

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

Aug 10 2026

Next Week At A Glance – 10-14 Aug 2026

A brief look at important company events and economic data releases next week

Aug 07 2026


Weekly Top Ten News Stories – 7 August 2026

Our top ten news stories from 30 July 2026 to 06 August 2026

Aug 07 2026

In Case You Missed It – BC Extra Upgrades & Downgrades – 07-08-26

A summary of the highlights from Broker Call Extra updates throughout the week past

Aug 07 2026

In Brief: Vista, Amcor & Charter Hall Social Infra

Strong results from Vista Group, an improving outlook for Charter Hall Social Infrastructure REIT, plus can Amcor’s FY26 result deliver on cost and synergy improvements?

Aug 07 2026


The Short Report – 06 Aug 2026

FNArena’s weekly update on short positions in the Australian share market

Aug 06 2026

Weekly Update On LICs & LITs – 04-Aug-2026

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Aug 04 2026

Uranium Week: Steady Rise In Term Requests

As far as activity and pricing in the U308 market were concerned, July was largely a non-event, but investors adopted a risk-off approach to uranium equities, as reflected in the decline of the Global X Uranium ETF (URA)

Aug 04 2026


9.1K Followers
26.7K Posts
@Filapek
Rudi Filapek-Vandyck @Filapek
13h
Citi on $Car Group: "We are a bit surprised with the quantum of the share price reaction and while a weaker macro could result in revenue growth coming in towards bottom-end of range, we do see the ongoing product development as positive and should underpin double-digit growth
@Filapek
Rudi Filapek-Vandyck @Filapek
17h
RBC Capital on Megaport $MP1: "Recent CEO meetings we hosted with US investors highlighted: "1) Megaport has transformed from a cloud-connectivity company into a three-pillar platform (network, compute, storage) post its Latitude acquisition, aimed at meeting on-demand
@Filapek
Rudi Filapek-Vandyck @Filapek
17h
RBC Capital on Integral Diagnostics $IDX: "The company has provided preliminary results for FY26, which came in below consensus expectations. "While we had flagged downside risks to consensus numbers in our preview note, we expect the operating miss to be taken negatively by
@Filapek
Rudi Filapek-Vandyck @Filapek
18h
RBC Capital on $CAR Group: "A largely in-line result from CAR with good guidance relative to present FY27 consensus expectations. "Not a lot of surprises even divisionally (ex. Investments) with segment beats and misses for both revenue and EBITDA not exceeding 3%. "With
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Citi on ResMed $RMD: "Following in-line sales for 4Q26 we have revised our FY27E revenue to include lower impact from the Astral recall than we previously assumed (USD75m vs USD200m) but tempered our gross margin expansion expectations. "A USD1.5b buyback (USD500m more than
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
That sound you are hearing in the background is from me having a good ole belly laugh 😉 - Spicing up the FriJay! https://t.co/bafCGlhA00
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Citi on James Hardie $JHX: "1Q27 EBITDA $422M, oddly ~4% over the top end of pre-reported range ($399-407M). "With S&T and DR&A within previous ranges, and guidance provided post quarter end, it appears the driver was share-based comp put below the line that provided a ~$15M
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
RBC Capital on James Hardie $JHX: "We expect a positive reaction in James Hardie's shares in trading today after the release of FQ127 results, which follows the company's preliminary results release from July 22. "We expect a positive reaction to the strong quarter and raised
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Citi on ResMed $RMD: "RMD's 4Q sales were in line with VA consensus with devices and masks both in line, but a stronger performance ex-Americas than in the Americas. "Gross margin was 46bps below consensus, although slightly ahead of our estimate. EPS was 2% ahead, but R&D
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
RBC Capital on ResMed $RMD: "Revenue was in line with consensus expectations, with a slight miss in Americas and SaaS being offset by a beat in RoW. "Gross margin was a miss to RBCe and Consensus and non-GAAP income from operations was a miss due to the lower gross margin and
FIND FNARENA ON

THE MARKETS

    Click item/line to change chart

  • Australia

    10 August 2026   Updated : 20:12   AEDT

    SPI Overnight

    9233.00

    +33.00

    0.36%

    NZ50

    13888.240

    +64.110

    0.460%

    All Ordinaries

    9424.10

    -21.00

    -0.22%

    S&P ASX 200

    9232.60

    -31.00

    -0.33%

    S&P ASX 300

    9162.70

    -27.20

    -0.30%

    Communication Services

    1689.70

    +28.20

    1.70%

    Consumer Discretionary

    4081.40

    -18.60

    -0.45%

    Consumer Staples

    13577.30

    +48.20

    0.36%

    Energy

    10441.10

    +4.80

    0.05%

    Financials

    9803.10

    -227.80

    -2.27%

    Health Care

    28380.90

    +404.70

    1.45%

    Industrials

    8580.30

    +4.00

    0.05%

    Info Technology

    1930.00

    +11.00

    0.57%

    Materials

    25242.10

    +304.20

    1.22%

    Real Estate

    3673.80

    -9.40

    -0.26%

    Utilities

    9488.70

    -22.00

    -0.23%

    A-REITs

    1709.60

    -4.80

    -0.28%

    All Technology Index

    3192.30

    +44.00

    1.40%

    Banks

    4122.60

    -117.10

    -2.76%

    Gold Index

    18204.20

    +463.20

    2.61%

    Metals & Mining

    8689.00

    +117.50

    1.37%

    Click item/line to change chart

  • Australasia

    10 August 2026   Updated : 20:12   AEDT

    AUD/USD

    0.7064

    0.00

    -0.04%

    AUD/NZD

    1.1984

    0.00

    -0.14%

    NZD/USD

    0.5894

    +0.00

    0.27%

    AUD/JPY

    112.24

    +0.88

    0.79%

    SGD/AUD

    1.11

    -0.01

    -1.33%

    AUD/EUR

    0.6114

    +0.00

    0.07%

    AUD/GBP

    0.5235

    0.00

    -0.11%

    AUDCAD

    0.9851

    0.00

    -0.11%

  • World

    10 August 2026   Updated : 20:12   AEDT

    CAD/USD

    0.7171

    +0.00

    0.07%

    EUR/JPY

    183.61

    +1.17

    0.64%

    EUR/USD

    1.1556

    0.00

    -0.01%

    GBP/USD

    1.3494

    +0.00

    0.21%

    USD/JPY

    158.88

    +1.08

    0.68%

    Click item/line to change chart

  • World

    10 August 2026   Updated : 20:12   AEDT

    FTSE100

    10877.50

    -23.59

    -0.22%

    DAX30

    26404.74

    +85.29

    0.32%

    Hang Seng

    25937.49

    +269.46

    1.05%

    Nikkei 225

    66970.22

    +1363.51

    2.08%

    NZ50

    13888.240

    +64.110

    0.460%

    DJIA

    54036.93

    +151.83

    0.28%

    S&P500

    7757.64

    +47.68

    0.62%

    Nasdaq Comp

    26690.62

    +342.26

    1.30%

    S&P500 VIX

    15.43

    +0.28

    1.85%

    US 10-year yield

    4.660

    -0.010

    -0.210%

    USD Index

    99.60

    -0.35

    -0.35%

  • Aus Stocks

    10 August 2026   Updated : 20:12   AEDT

    Amcor (US)

    47.86

    +0.80

    1.70%

    Newmont (US)

    112.98

    +7.55

    7.16%

    Rio Tinto (UK)

    7556.00

    +28.00

    0.37%

    BHP Group (US)

    90.41

    +2.51

    2.86%

    Rio Tinto (US)

    101.10

    +1.45

    1.46%

    ResMed (US)

    211.94

    -11.30

    -5.06%

    South32 (UK)

    267.80

    +7.80

    3.00%

    James Hardie (US)

    30.23

    +2.23

    7.96%

    Janus Henderson (US)

    51.95

    -0.02

    -0.04%

    Click item/line to change chart

  • Metals & Minerals

    10 August 2026   Updated : 07:21   AEDT

    Gold (oz)

    4343.43

    +103.30

    2.44%

    Silver (oz)

    63.54

    +2.01

    3.27%

    Copper (lb)

    6.5700

    -0.13

    -1.94%

    Aluminium (lb)

    1.4880

    +0.02

    1.56%

    Nickel (lb)

    7.5975

    +0.07

    0.90%

    Zinc (lb)

    1.7173

    +0.02

    1.28%

    Copper (t)

    14480.28

    -286.52

    -1.94%

    Aluminium (t)

    3279.50

    +50.50

    1.56%

    Nickel (t)

    16745.00

    +150.00

    0.90%

    Zinc (t)

    3785.00

    +48.00

    1.28%

    Uranium (lb) weekly

    86.75

    +0.25

    0.29%

    Iron Ore (t)

    94.45

    -0.83

    -0.87%

  • Energy

    10 August 2026   Updated : 07:19   AEDT

    West Texas Crude

    78.18

    -0.09

    -0.11%

    Brent Crude

    83.55

    -0.05

    -0.06%

CALENDAR

Tuesday, 11 August 2026
AU July Business Survey
AU RBA rate decision
AU RBA Statement on Monetary Policy
US July existing home sales
US July NFIB
360earnings report
AOVFY26 earnings report
CIPFY26 earnings report
CPUFY26 earnings report
CRNFY26 earnings report
HLI1H26 earnings report
JBHFY26 earnings report
SGHFY26 earnings report

ALL WEATHER STOCKS

CodeCompanyPrice
CARCAR GROUP LIMITED

market icon up$29.70

REAREA GROUP LIMITED

market icon up$175.34

RMDRESMED INC

market icon up$30.09

TNETECHNOLOGY ONE LIMITED

market icon up$33.13

WOWWOOLWORTHS GROUP LIMITED

market icon up$40.66

WEEKLY PDF

Stories To Read From FNArena


WEEK 32
icon pdf

WEEK 31
icon pdf

WEEK 30
icon pdf

WEEK 29
icon pdf

WEEK 28
icon pdf

FNARENA TALKS

FNARENA WINDOWS

Window on BUILDING PRODUCTS & SERVICES

Weak Market, But James Hardie Is Confident

Amidst a difficult US housing market backdrop, James Hardie is concentrating on further organic growth following a strong first quarter

Aug 10 2026


Window on REITS

Australian Listed Real Estate Tables – 10-08-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

Aug 10 2026


Window on WEALTH MANAGEMENT & INVESTMENTS

Pinnacle’s FY26 ‘Messy’ But Positive

Multi-affiliate asset manager Pinnacle Investment Management beat consensus on funds under management but fell well short on profit

Aug 07 2026


GEN AI

AI Infrastructure: From Capex To Productivity

Despite growing investor scepticism, analysts believe the next phase of the AI investment cycle will be driven by productivity gains, data centre expansion and a widening group of ASX-listed beneficiaries

Jul 30 2026


FEATURE STORIES

Australian Banks, Bad Debts And The Budget

The March quarter turned sour for the banks and bad debt provisions were increased, ahead of a federal budget that will have significant impact on mortgage demand

May 20 2026